john
nichol
xiaop
dong
gu
jiang
malik
peiri
respirolog
sever
acut
respiratori
syndrom
sar
caus
novel
coronaviru
call
sar
coronaviru
sarscov
well
character
cohort
sar
evid
recent
sarscov
infect
genom
sarscov
sequenc
relat
previous
known
human
anim
coronavirus
probabl
sarscov
anim
viru
adapt
humanhuman
transmiss
recent
past
viru
found
nasopharyng
aspir
urin
stool
sar
patient
second
gener
revers
transcriptas
polymeras
chain
reaction
assay
abl
detect
sarscov
nasopharyng
aspir
approxim
patient
sar
within
first
day
ill
seroconvers
sarscov
use
immunofluoresc
infect
cell
excel
method
confirm
diagnosi
antibodi
respons
appear
around
day
ill
within
first
day
histolog
pictur
acut
phase
diffus
alveolar
damag
dad
mixtur
inflammatori
infiltr
oedema
hyalin
membran
format
desquam
pneumocyt
promin
consist
day
ill
pictur
chang
one
organ
dad
increas
fibrosi
squamou
metaplasia
multinucl
giant
cell
role
cytokin
pathogenesi
sar
still
unclear
sever
acut
respiratori
syndrom
sar
caus
novel
coronaviru
call
sar
coronaviru
sarscov
well
characteris
cohort
sar
evid
recent
sarscov
infect
experiment
infect
cynomolg
macaqu
sarscov
lead
sarslik
diseas
associ
lung
patholog
giant
cell
reminisc
human
diseas
investig
outbreak
sar
also
reveal
coinfect
human
metapneumoviru
pathogen
proport
patient
whether
coinfect
contribut
enhanc
pathogenesi
transmiss
diseas
still
uncertain
genom
sarscov
indic
novel
viru
within
famili
coronavirida
close
relat
human
anim
coronavirus
known
date
healthi
human
serolog
evid
past
sarscov
infect
close
relat
virus
recent
isol
anim
civet
cat
probabl
sarscov
anim
viru
adapt
humanhuman
transmiss
recent
past
presenc
anim
reservoir
impli
possibl
viru
cross
human
initi
outbreak
diseas
futur
mani
respiratori
virus
includ
coronavirus
season
sarscov
yet
unknown
therefor
possibl
similar
coronavirus
winter
may
conduc
transmiss
sarscov
sarscov
detect
cultur
cell
revers
transcriptas
polymeras
chain
reaction
rtpcr
respiratori
secret
faec
urin
also
less
frequent
blood
infect
thu
restrict
respiratori
tract
alon
presenc
diarrhoea
proport
patient
one
indic
fact
contrast
respiratori
virus
sarscov
viral
load
respiratori
tract
faec
low
first
day
ill
peak
around
day
diseas
account
low
sensit
first
gener
diagnost
test
first
day
ill
may
also
explain
part
unusu
predilect
viru
spread
among
health
care
worker
patient
usual
infecti
later
ill
time
mani
alreadi
hospit
respiratori
specimen
faec
use
clinic
specimen
rtpcr
diagnosi
faec
less
satisfactori
specimen
first
day
ill
nasopharyng
aspir
respiratori
specimen
choic
throat
swab
also
use
though
lower
diagnost
yield
patient
produc
sputum
also
excel
clinic
specimen
howev
patient
cough
nonproduct
second
gener
rtpcr
assay
abl
detect
sarscov
nasopharyng
aspir
approxim
patient
sar
within
first
day
ill
seroconvers
sarscov
use
immunofluoresc
infect
cell
excel
method
confirm
diagnosi
although
antibodi
respons
appear
around
day
ill
diagnosi
retrospect
natur
sinc
patient
delay
antibodi
respons
advis
obtain
convalesc
serum
least
day
ideal
day
onset
diseas
especi
patient
high
dose
steroid
therapi
acut
stage
ill
understand
pathogenesi
sar
bedevil
fact
avail
autopsi
tissu
patient
die
later
ill
time
initi
viral
patholog
obscur
secondari
infect
chang
due
ventil
therapi
steroid
immun
modul
despit
limit
autopsi
materi
possibl
determin
two
phase
sar
pneumonia
within
first
day
histolog
pictur
acut
phase
diffus
alveolar
damag
dad
mixtur
inflammatori
infiltr
oedema
hyalin
membran
format
fig
desquam
pneumocyt
promin
consist
one
report
initi
publish
chines
later
english
anoth
journal
mention
viral
intracytoplasm
inclus
bodi
identifi
hong
kong
singapor
case
day
ill
pictur
chang
one
organ
dad
increas
fibrosi
squamou
metaplasia
multinucl
giant
cell
fig
giant
cell
also
seen
experiment
induc
sar
pneumonia
primat
coronavirus
known
give
rise
syncitia
histolog
appear
distinct
enough
make
diagnosi
without
viral
detect
human
well
primat
sarscov
identifi
lung
major
postmortem
examin
perform
patient
sar
involv
patient
diseas
durat
day
patient
organ
stage
dad
case
patient
succumb
increas
number
interstiti
macrophag
int
alveolar
macrophag
present
focal
haemophagocytosi
seen
former
experiment
studi
primat
found
tracheobronchi
lymph
node
spleen
enlarg
low
number
lymphocyt
lymphopenia
consist
find
major
sar
case
may
similar
aetiolog
influenzainduc
leukopenia
primat
studi
also
found
increas
number
alveolar
macrophag
also
present
singl
earli
case
sar
influenza
explain
chemokin
stimul
influenza
preferenti
recruit
blood
mononuclear
cell
site
infect
review
normal
lung
suppos
development
endpoint
stage
monocyt
int
macrophag
repres
precursor
stage
two
also
differ
functionam
effect
nonspecif
firstlin
defenc
infecti
agent
wherea
int
macrophag
cooper
interstiti
lymphocyt
induc
specif
immun
respons
though
cytokin
may
play
major
role
fibrot
stage
dad
role
undu
immunopatholog
lung
damag
observ
earli
sar
remain
unclear
anim
model
tnf
upregul
macrophag
led
tlymphocyt
predomin
alveol
progress
histolog
pictur
resembl
idiopath
pulmonari
fibrosi
immunohistochem
stain
sar
patient
shown
presenc
tlymphocyt
alveolar
wall
interstitium
sarscov
similar
cov
infect
earli
clearanc
viru
day
period
similar
exud
phase
sar
dad
find
suggest
first
phase
diseas
cell
damag
macrophag
tlymphocyt
infiltr
second
stage
organ
fibrot
dad
aggrav
mechan
ventil
cytokin
play
minor
role
small
quantiti
viru
still
present
lung
tissu
studi
primat
model
may
elucid
pathogenesi
lung
damag
provid
better
foundat
patient
manag
